With the recent approval by the DEA to move cannabis off of Schedule 1 (with the most dangerous drugs) and onto Schedule 3, it looks like the Cannabis industry is about to enter a massive growth phase. IRC 280e will not be relevant anymore, taxes will be lowered and cash flows will be higher for these companies which will bring in a flood of capital.
What does this all mean? What are the facts and myths, and are accountants needed at all? Join this webinar to learn what it will mean, as well as a deeper dive into cannabis GAAP and tax inventory accounting.
Learning Objectives:
DOPE CFO
Founder and Owner
[email protected]
(405) 990-4370
Andrew founded DOPE CFO and is an expert in cannabis startups, CFO services, turnaround and high-growth strategies, capital sourcing, mergers, exits, and wealth protection. He has served in the "Big 4," including PriceWaterhouseCoopers, and is the winner of the 1995 Gold Medal Award for the CPA exam’s highest score. Andrew was runner up for Portland Business Journal's CFO of the Year in 2017, making him the first cannabis CFO ever to be nominated.